Document Detail


Clinical surveillance of a tined, bipolar, silicone-insulated ventricular pacing lead.
MedLine Citation:
PMID:  16627421     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: This study assesses short- and long-term performance of the S80TB ventricular lead manufactured by Sorin Biomedica, Italy. METHODS AND RESULTS: Three hundred and thirty leads were implanted and had complete follow-up with us for a minimum of 60 months or up to failure, removal, and/or patient death (mean 40 months, range: 1 day to 81 months). Thirty-two patients (9.6%) had spontaneous lead-related complications: 7 (2.1%) occurred during the first week; 25 (7.6%) had chronic complications, of which 20 (6.1%) necessitated re-operations; 3 (0.9%) were lead material failures. Of the 110 re-operations (90 pacemaker replacements and 20 operations due to complications), 7 additional cases (6.4%) were complicated by unique connector damage that occurred during disconnection of the lead from the connector block. The Kaplan-Meier estimated 5-year lead survival free of lead material failure and free of any significant lead complication were 97.9 and 87%, respectively. CONCLUSION: The S80TB lead demonstrates an acceptable rate of acute and chronic spontaneous complications and very few lead material failures over 5 years of follow-up. However, there seems to be a relatively high incidence of connector damage during disconnection from the connector block. Extra caution is required during those procedures in patients with this lead.
Authors:
Igor A Lipchenca; David S Bar-Lev; David M Luria; Osnat T Gurevitz; Chava Granit; Zeev Rotstein; Eli I Ovsyshcher; Michael Eldar; Michael Glikson
Publication Detail:
Type:  Journal Article     Date:  2006-01-09
Journal Detail:
Title:  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology     Volume:  8     ISSN:  1099-5129     ISO Abbreviation:  Europace     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-04-21     Completed Date:  2006-06-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883649     Medline TA:  Europace     Country:  England    
Other Details:
Languages:  eng     Pagination:  118-21     Citation Subset:  IM    
Affiliation:
Heart Institute Sheba Medical Center, Tel Hashomer, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Cardiac Pacing, Artificial*
Electrodes, Implanted
Equipment Design
Equipment Failure
Equipment Failure Analysis
Female
Follow-Up Studies
Humans
Male
Middle Aged
Pacemaker, Artificial / adverse effects*
Retrospective Studies
Survival Rate
Treatment Outcome
Ventricular Fibrillation / mortality,  therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Passive electrode effect reduces defibrillation threshold in bi-filament middle cardiac vein defibri...
Next Document:  Cost of diagnosis and treatment of syncope in patients admitted to a cardiology unit.